Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer.
Dehn H, Høgdall EV, Johansen JS, Jørgensen M, Price PA, Engelholm SA, Høgdall CK. Dehn H, et al. Among authors: hogdall ev, hogdall ck. Acta Obstet Gynecol Scand. 2003 Mar;82(3):287-93. doi: 10.1034/j.1600-0412.2003.00010.x. Acta Obstet Gynecol Scand. 2003. PMID: 12694127
Plasma tetranectin and ovarian neoplasms.
Høgdall CK, Høgdall EV, Hørding U, Daugaard S, Clemmensen I, Nørgaard-Pedersen B, Toftager-Larsen K. Høgdall CK, et al. Among authors: hogdall ev. Gynecol Oncol. 1991 Nov;43(2):103-7. doi: 10.1016/0090-8258(91)90053-8. Gynecol Oncol. 1991. PMID: 1743549
Metastasis to the breast from an ovarian carcinoma.
Petersen BL, Høgdall E, Kryger-Baggesen N. Petersen BL, et al. Acta Obstet Gynecol Scand. 1999 Oct;78(9):826-7. doi: 10.1034/j.1600-0412.1999.780918.x. Acta Obstet Gynecol Scand. 1999. PMID: 10535351 No abstract available.
Stability of YKL-40 concentration in blood samples.
Høgdall EV, Johansen JS, Kjaer SK, Price PA, Blaakjaer J, Høgdall CK. Høgdall EV, et al. Among authors: hogdall ck. Scand J Clin Lab Invest. 2000 Jul;60(4):247-51. doi: 10.1080/00365510050184886. Scand J Clin Lab Invest. 2000. PMID: 10943594
80 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page